Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Carter, Bing Z.
807  Ergebnisse:
Personensuche X
?
1

Correction: Mitochondrial regulation of GPX4 inhibition–med..:

Akiyama, Hiroki ; Zhao, Ran ; Ostermann, Lauren B....
Leukemia.  38 (2024)  4 - p. 926-926 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Inhibition of menin, BCL-2, and FLT3 combined with a hypome..:

Carter, Bing Z. ; Mak, Po Yee ; Tao, Wenjing...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
3

Epichaperome inhibition targets TP53-mutant AML and AML ste..:

Carter, Bing Z. ; Mak, Po Yee ; Muftuoglu, Muharrem...
Blood.  142 (2023)  12 - p. 1056-1070 , 2023
Link: https://doi.org/10.1182/..
 
?
4

Bcl-2 inhibition combined with PPARα activation synergistic..:

Xie, Chendi ; Zhou, Hui ; Qin, Dongmei...
Cell Death & Disease.  14 (2023)  8 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
5

Mitochondrial regulation of GPX4 inhibition–mediated ferrop..:

Akiyama, Hiroki ; Zhao, Ran ; Ostermann, Lauren B....
Leukemia.  38 (2023)  4 - p. 729-740 , 2023
Link: https://doi.org/10.1038/..
 
?
6

Combined inhibition of BCL-2 and MCL-1 overcomes BAX defici..:

Carter, Bing Z. ; Mak, Po Yee ; Tao, Wenjing...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
7

ABCC1 and glutathione metabolism limit the efficacy of BCL-..:

Ebner, Jessica ; Schmoellerl, Johannes ; Piontek, Martin...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
8

Correction: Combined inhibition of BCL-2 and MCL-1 overcome..:

Carter, Bing Z. ; Mak, Po Yee ; Tao, Wenjing...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
9

Molecular Mechanisms of Ferroptosis and Updates of Ferropto..:

Akiyama, Hiroki ; Carter, Bing Z. ; Andreeff, Michael.
Cells.  12 (2023)  8 - p. 1128 , 2023
Link: https://doi.org/10.3390/..
 
?
10

Poster: AML-147 C-MYC Targeting by Degradation: Novel Dual ..:

Nishida, Yuki ; Scruggs, Darah A ; Ayoub, Edward...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S127 , 2022
Link: https://doi.org/10.1016/..
 
?
11

SOHO State of the Art Updates and Next Questions | Beyond B..:

Maiti, Abhishek ; Carter, Bing Z. ; Andreeff, Michael.
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  9 - p. 652-658 , 2022
Link: https://doi.org/10.1016/..
 
?
12

AML-147 C-MYC Targeting by Degradation: Novel Dual c-Myc/GS..:

Nishida, Yuki ; Scruggs, Darah A ; Ayoub, Edward...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S218 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Application of machine learning methods in clinical trials ..:

Wang, Yizhuo ; Carter, Bing Z ; Li, Ziyi.
JAMIA Open.  5 (2022)  1 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
14

Therapeutic synergy of Triptolide and MDM2 inhibitor agains..:

Chen, Qinwei ; Deng, Suqi ; Deng, Manman...
Experimental Hematology & Oncology.  11 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
15

EXABS-147-AML How Do We Overcome Resistance to Venetoclax:

Saxena, Kapil ; Carter, Bing Z. ; Konopleva, Marina
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S55-S57 , 2022
Link: https://doi.org/10.1016/..
 
1-15